RU2662358C2 - Способы биологических исследований с использованием клеток для контроля качества нутрицевтических продуктов и лекарственных средств - Google Patents

Способы биологических исследований с использованием клеток для контроля качества нутрицевтических продуктов и лекарственных средств Download PDF

Info

Publication number
RU2662358C2
RU2662358C2 RU2014136408A RU2014136408A RU2662358C2 RU 2662358 C2 RU2662358 C2 RU 2662358C2 RU 2014136408 A RU2014136408 A RU 2014136408A RU 2014136408 A RU2014136408 A RU 2014136408A RU 2662358 C2 RU2662358 C2 RU 2662358C2
Authority
RU
Russia
Prior art keywords
atcc
specified
pta
cell
proliferation
Prior art date
Application number
RU2014136408A
Other languages
English (en)
Russian (ru)
Other versions
RU2014136408A (ru
Inventor
Жозе А. ХАЛПЕРИН
Майкл ЧОРЕВ
Хусейн АКТАС
Original Assignee
Президент Энд Феллоуз Оф Гарвард Колледж
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Президент Энд Феллоуз Оф Гарвард Колледж filed Critical Президент Энд Феллоуз Оф Гарвард Колледж
Publication of RU2014136408A publication Critical patent/RU2014136408A/ru
Application granted granted Critical
Publication of RU2662358C2 publication Critical patent/RU2662358C2/ru

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/02—Food
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
RU2014136408A 2012-07-20 2013-07-22 Способы биологических исследований с использованием клеток для контроля качества нутрицевтических продуктов и лекарственных средств RU2662358C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261674180P 2012-07-20 2012-07-20
US61/674,180 2012-07-20
PCT/US2013/051433 WO2014015328A1 (en) 2012-07-20 2013-07-22 Cell based quality control bioassays for nutriceutical and medicinal products

Publications (2)

Publication Number Publication Date
RU2014136408A RU2014136408A (ru) 2016-09-10
RU2662358C2 true RU2662358C2 (ru) 2018-07-25

Family

ID=48916225

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2014136408A RU2662358C2 (ru) 2012-07-20 2013-07-22 Способы биологических исследований с использованием клеток для контроля качества нутрицевтических продуктов и лекарственных средств

Country Status (22)

Country Link
US (1) US9952200B2 (enExample)
EP (1) EP2820418B1 (enExample)
JP (1) JP6200501B2 (enExample)
KR (1) KR102136763B1 (enExample)
CN (1) CN104641231B (enExample)
AU (1) AU2013292266B2 (enExample)
CA (1) CA2866175C (enExample)
CL (1) CL2014002530A1 (enExample)
CO (1) CO7151536A2 (enExample)
DK (1) DK2820418T3 (enExample)
ES (1) ES2656941T3 (enExample)
HU (1) HUE036166T2 (enExample)
IN (1) IN2014DN07866A (enExample)
MA (1) MA35924B1 (enExample)
MX (1) MX356147B (enExample)
NO (1) NO2912013T3 (enExample)
PE (1) PE20142297A1 (enExample)
PL (1) PL2820418T3 (enExample)
PT (1) PT2820418T (enExample)
RU (1) RU2662358C2 (enExample)
WO (1) WO2014015328A1 (enExample)
ZA (1) ZA201406653B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107217087B (zh) * 2016-03-22 2019-12-10 中国石油化工股份有限公司 迅速测量油田污水和成品油中细菌含量的方法
CN115785247B (zh) * 2022-12-22 2025-06-24 中国农业大学 一种猪流行性腹泻病毒抗性相关蛋白质eif2a及其相关生物材料和应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008008333A2 (en) * 2006-07-11 2008-01-17 President And Fellows Of Harvard College Bioassays for quality control of nutriceuticals that inhibit, upregulate or otherwise modulate translation initiation
WO2010138820A2 (en) * 2009-05-28 2010-12-02 President And Fellows Of Harvard College N,n-diarylurea compounds and n,n'-diarylthiourea compounds as inhibitors of translation initiation

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4318846A (en) 1979-09-07 1982-03-09 Syva Company Novel ether substituted fluorescein polyamino acid compounds as fluorescers and quenchers
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4757141A (en) 1985-08-26 1988-07-12 Applied Biosystems, Incorporated Amino-derivatized phosphite and phosphate linking agents, phosphoramidite precursors, and useful conjugates thereof
US5091519A (en) 1986-05-01 1992-02-25 Amoco Corporation Nucleotide compositions with linking groups
US5151507A (en) 1986-07-02 1992-09-29 E. I. Du Pont De Nemours And Company Alkynylamino-nucleotides
US4843155A (en) 1987-11-19 1989-06-27 Piotr Chomczynski Product and process for isolating RNA
US5066580A (en) 1988-08-31 1991-11-19 Becton Dickinson And Company Xanthene dyes that emit to the red of fluorescein
US5366860A (en) 1989-09-29 1994-11-22 Applied Biosystems, Inc. Spectrally resolvable rhodamine dyes for nucleic acid sequence determination
US5188934A (en) 1989-11-14 1993-02-23 Applied Biosystems, Inc. 4,7-dichlorofluorescein dyes as molecular probes
US5654419A (en) 1994-02-01 1997-08-05 The Regents Of The University Of California Fluorescent labels and their use in separations
US5854033A (en) 1995-11-21 1998-12-29 Yale University Rolling circle replication reporter systems
US5800996A (en) 1996-05-03 1998-09-01 The Perkin Elmer Corporation Energy transfer dyes with enchanced fluorescence
US5847162A (en) 1996-06-27 1998-12-08 The Perkin Elmer Corporation 4, 7-Dichlororhodamine dyes
US6322901B1 (en) 1997-11-13 2001-11-27 Massachusetts Institute Of Technology Highly luminescent color-selective nano-crystalline materials
US5990479A (en) 1997-11-25 1999-11-23 Regents Of The University Of California Organo Luminescent semiconductor nanocrystal probes for biological applications and process for making and using such probes
US6207392B1 (en) 1997-11-25 2001-03-27 The Regents Of The University Of California Semiconductor nanocrystal probes for biological applications and process for making and using such probes
US6426513B1 (en) 1998-09-18 2002-07-30 Massachusetts Institute Of Technology Water-soluble thiol-capped nanocrystals
US6251303B1 (en) 1998-09-18 2001-06-26 Massachusetts Institute Of Technology Water-soluble fluorescent nanocrystals
US6649138B2 (en) 2000-10-13 2003-11-18 Quantum Dot Corporation Surface-modified semiconductive and metallic nanoparticles having enhanced dispersibility in aqueous media
US6576291B2 (en) 2000-12-08 2003-06-10 Massachusetts Institute Of Technology Preparation of nanocrystallites
ATE556845T1 (de) 2001-07-20 2012-05-15 Life Technologies Corp Lumineszierende nanopartikel und ihre herstellung
WO2007008221A2 (en) * 2004-08-10 2007-01-18 President And Fellows Of Harvard College DETECTION OF PHOSPHORYLATED eIF2α AS A DIAGNOSTIC TEST FOR EFFICIENCY AND SENSITVITY OF TRANSLATION INITIATION INHIBITORS IN THE TREATMENT OF CANCER AND OTHE R PROLIFERATIVE DISEASES
JP2012523837A (ja) * 2009-04-17 2012-10-11 プレジデント アンド フェローズ オブ ハーバード カレッジ 栄養医薬品および医薬品のための品質管理バイオアッセイ
CN101671669B (zh) * 2009-08-27 2012-05-02 浙江大学 一种肝癌靶向性基因表达元件ae及其应用

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008008333A2 (en) * 2006-07-11 2008-01-17 President And Fellows Of Harvard College Bioassays for quality control of nutriceuticals that inhibit, upregulate or otherwise modulate translation initiation
WO2010138820A2 (en) * 2009-05-28 2010-12-02 President And Fellows Of Harvard College N,n-diarylurea compounds and n,n'-diarylthiourea compounds as inhibitors of translation initiation

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
SVERINE DENOYELLE et al. "In vitro inhibition of translation initiation by, -diarylureaspotential anti-cancer agents", BIOORGANIC @ MEDICAL CEMISTRY LETTERS, PERGAMON, vol. 22, N1, 31 October 2011, p. 402-409. *
TING CHEN et al. "Chemical genetics identify Eif2[alpha] kinase heme-regulated ingibitor as an anticancer target", NATURE CHEMICAL BIOLOGY. vol. 7, N9, 1 September 2011, p. 610-616. *
TING CHEN et al. "Chemical genetics identify Eif2[alpha] kinase heme-regulated ingibitor as an anticancer target", NATURE CHEMICAL BIOLOGY. vol. 7, N9, 1 September 2011, p. 610-616. TING CHEN et al. "Chemical genetics identify Eif2[alpha] kinase heme-regulated ingibitor as an anticancer target", NATURE CHEMICAL BIOLOGY. vol. 7, N9, 1 September 2011, p. 610-616. *

Also Published As

Publication number Publication date
CL2014002530A1 (es) 2015-01-09
KR20150035496A (ko) 2015-04-06
EP2820418A1 (en) 2015-01-07
JP6200501B2 (ja) 2017-09-20
ES2656941T3 (es) 2018-03-01
MX2014012542A (es) 2014-11-21
US20150301023A1 (en) 2015-10-22
NO2912013T3 (enExample) 2018-03-10
AU2013292266B2 (en) 2019-01-03
KR102136763B1 (ko) 2020-08-13
US9952200B2 (en) 2018-04-24
CA2866175A1 (en) 2014-01-23
CA2866175C (en) 2021-04-20
PE20142297A1 (es) 2014-12-19
PL2820418T3 (pl) 2018-05-30
EP2820418B1 (en) 2017-12-06
JP2015524269A (ja) 2015-08-24
ZA201406653B (en) 2022-05-25
MA35924B1 (fr) 2014-12-01
AU2013292266A1 (en) 2014-09-25
RU2014136408A (ru) 2016-09-10
CN104641231B (zh) 2016-09-07
DK2820418T3 (en) 2018-02-12
CN104641231A (zh) 2015-05-20
IN2014DN07866A (enExample) 2015-04-24
MX356147B (es) 2018-05-15
PT2820418T (pt) 2018-02-12
CO7151536A2 (es) 2014-12-29
HUE036166T2 (hu) 2018-06-28
WO2014015328A1 (en) 2014-01-23

Similar Documents

Publication Publication Date Title
Yan et al. Endothelial nitric oxide synthase deficiency in mice results in reduced chondrocyte proliferation and endochondral bone growth
JP6185965B2 (ja) 栄養医薬品および医薬品のための品質管理バイオアッセイ
RU2662358C2 (ru) Способы биологических исследований с использованием клеток для контроля качества нутрицевтических продуктов и лекарственных средств
Han et al. Activation of SIK2 inhibits gluconeogenesis and alleviates lipogenesis‐induced inflammatory response by SIK2‐CRTC2‐ACC1 in hepatocytes of large yellow croaker (Larimichthys crocea)
AU2015201847B2 (en) Quality control bioassays for nutriceutical and medicinal products
JP2021166471A (ja) 抗肥満物質のスクリーニング方法及び抗肥満物質のスクリーニング用キット